Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections

To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested serum from 30 persons with breakthrough infection after 2-dose vaccination. Cross-variant neutralizing activity was comparable to that after 3-dose va...

Full description

Saved in:
Bibliographic Details
Main Authors: Pinkus Tober-Lau, Henning Gruell, Kanika Vanshylla, Willi M. Koch, David Hillus, Philipp Schommers, Isabelle Suárez, Norbert Suttorp, Leif Erik Sander, Florian Klein, Florian Kurth
Format: Artigo
Language:Inglês
Published: Centers for Disease Control and Prevention 2022-05-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
2019 novel coronavirus disease
coronavirus disease
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
viruses
Online Access:https://wwwnc.cdc.gov/eid/article/28/5/22-0271_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items